Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
PLRX holding history
Pliant Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLRX overviewAll 13F holders of PLRXFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −455,823−100.0% | Sold out | Holders |
| Q2 2023 | 455,823 | $8.26M | <0.1% | −1,030,347−69.3% | Reduced | Holders |
| Q1 2023 | 1,486,170 | $39.5M | 0.1% | +985,382+196.8% | Added | Holders |
| Q4 2022 | 500,788 | $9.68M | <0.1% | +1,255+0.3% | Added | Holders |
| Q3 2022 | 499,533 | $10.4M | <0.1% | +180,774+56.7% | Added | Holders |
| Q2 2022 | 318,759 | $2.55M | <0.1% | +21,725+7.3% | Added | Holders |
| Q1 2022 | 297,034 | $2.08M | <0.1% | +5,220+1.8% | Added | Holders |
| Q4 2021 | 291,814 | $3.94M | <0.1% | −2,843−1.0% | Reduced | Holders |
| Q3 2021 | 294,657 | $4.97M | <0.1% | −3,936−1.3% | Reduced | Holders |
| Q2 2021 | 298,593 | $8.70M | <0.1% | −28,501−8.7% | Reduced | Holders |
| Q1 2021 | 327,094 | $12.9M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.